Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study.
Philipp Koehler, Saskia von Stillfried, Jorge Garcia Borrega...
https://pubmed.ncbi.nlm.nih.gov/35144992Actively Recruiting
All Genders
ID01731353
FungiScope - A Global Emerging Fungal Infection Registry
Led by University of Cologne · Updated on 2023-12-05
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Cologne
Lead Sponsor
P
Pfizer
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.
CONDITIONS
Brief Title
FungiScope - A Global Emerging Fungal Infection Registry
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
- Cultural, histopathological, antigen or DNA evidence of invasive fungal infection
You will not qualify if you...
- Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci
- Endemic fungal infection such as coccidioidomycosis or histoplasmosis
- Colonisation or other non-invasive infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Trial Site Locations
Total: 1 location
1
University Hospital Cologne
Cologne, North Rhine-Westphalia, Germany, 50937
Actively Recruiting
Loading map...
Research Team
O
Oliver A Cornely, Prof.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Disseminated Fusariosis in Immunocompromised Children-Analysis of Recent Cases Identified in the Global Fungiscope Registry.
Angela Hassler, Adrian Lieb, Danila Seidel...
https://pubmed.ncbi.nlm.nih.gov/27846057Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Francisco M Marty, Luis Ostrosky-Zeichner, Oliver A Cornely...
https://pubmed.ncbi.nlm.nih.gov/26969258